Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

UPMC crosses Abridge for $15m

UPMC crosses Abridge for $15m

Oct 8, 2020 • James Mawson

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Abridge, a US-based medical care advisory service, launched on Monday with $15m in seed and series A funding from investors including UPMC Enterprises, the investment arm of University of Pittsburgh Medical Center (UPMC).
Venture capital firm Union Square Ventures led both rounds, and the other participants included VC firms Bessemer Venture Partners, Pillar and KdT Ventures and an angel syndicate comprised of Esther Dyson, Aneesh Chopra and Zen Chu.
Abridge has developed software that provides users with a transcript of conversations they have had with doctors, using machine learning to highlight crucial definitions from a list of more than 400,000 terms in addition to instructions on self-care or medication.
The money will be used to grow the company’s team and improve its product and machine learning technology.
– A version of this article first appeared on our sister site, Global Corporate Venturing.

James Mawson

James Mawson is founder and chief executive of Global Venturing.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

Abridge, a US-based medical care advisory service, launched on Monday with $15m in seed and series A funding from investors including Pittsburgh, Pennsylvania-based healthcare provider UPMC.

Venture capital firm Union Square Ventures led both rounds, and the other participants included VC firms Bessemer Venture Partners, Pillar and KdT Ventures and an angel syndicate comprised of Esther Dyson, Aneesh Chopra and Zen Chu.

Abridge has developed software that provides users with a transcript of conversations they have had with doctors, using machine learning to highlight crucial definitions from a list of more than 400,000 terms in addition to instructions on self-care or medication.

The money will be used to grow the company’s team and improve its product and machine learning technology.

James Mawson

James Mawson is founder and chief executive of Global Venturing.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here